Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MGI Pharma files for follow-on

Cancer company MOGN filed to sell 4 million shares in

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE